In last trading session, Lucid Diagnostics Inc (NASDAQ:LUCD) saw 79118.0 shares changing hands with its beta currently measuring 1.45. Company’s recent per share price level of $0.75 trading at -$0.03 or -3.83% at ring of the bell on the day assigns it a market valuation of $39.32M. That closing price of LUCD’s stock is at a discount of -129.33% from its 52-week high price of $1.72 and is indicating a premium of 16.0% from its 52-week low price of $0.63. Taking a look at company’s average trading volume volume of 195.37K if we extend that period to 3-months.
For Lucid Diagnostics Inc (LUCD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lucid Diagnostics Inc (NASDAQ:LUCD) trade information
Upright in the red during last session for losing -3.83%, in the last five days LUCD remained trading in the red while hitting it’s week-highest on Friday, 06/28/24 when the stock touched $0.75 price level, adding 16.45% to its value on the day. Lucid Diagnostics Inc’s shares saw a change of -46.80% in year-to-date performance and have moved -10.79% in past 5-day. Lucid Diagnostics Inc (NASDAQ:LUCD) showed a performance of -15.21% in past 30-days.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 75.0% to its current value. Analysts have been projecting 2.5 as a low price target for the stock while placing it at a high target of 3.1. It follows that stock’s current price would drop -233.33% in reaching the projected high whereas dropping to the targeted low would mean a loss of -233.33% for stock’s current value.
Lucid Diagnostics Inc (LUCD) estimates and forecasts
Statistics highlight that Lucid Diagnostics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -46.04% of value to its shares in past 6 months, showing an annual growth rate of -15.22% while that of industry is 11.90. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -110.66% during past 5 years.
LUCD Dividends
Lucid Diagnostics Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
